<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress/2.0.2" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>technewsblog.net</title>
	<link>http://biotech.technewsblog.net</link>
	<description></description>
	<pubDate>Tue, 19 Aug 2008 11:09:07 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.0.2</generator>
	<language>en</language>
			<item>
		<title>Dealmaking and Financing: Mergers and Acquisitions in the &#8230; - MarketWatch</title>
		<link>http://biotech.technewsblog.net/2008/08/19/dealmaking-and-financing-mergers-and-acquisitions-in-the-marketwatch/</link>
		<comments>http://biotech.technewsblog.net/2008/08/19/dealmaking-and-financing-mergers-and-acquisitions-in-the-marketwatch/#comments</comments>
		<pubDate>Tue, 19 Aug 2008 11:09:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/19/dealmaking-and-financing-mergers-and-acquisitions-in-the-marketwatch/</guid>
		<description><![CDATA[Dealmaking and Financing: Mergers and Acquisitions in the &#8230; - MarketWatch

Dealmaking and Financing: Mergers and Acquisitions in the &#8230;
MarketWatch - 23 hours ago
No facet of the biotech, specialty, or generics industries is being ignored; no technology platform, clinical product, or research program is unexplored or &#8230;
Discover Key Issues to Consider When Bringing Biologics to Market [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.marketwatch.com/news/story/dealmaking-financing-mergers-acquisitions-pharmaceuticals/story.aspx%3Fguid%3D%257B04B64222-C339-4D4E-9E8C-E3F650C66A10%257D%26dist%3Dhppr&#038;cid=1238016792&#038;ei=zamqSPLiEZS8-wG7jMH4DQ&#038;usg=AFQjCNHJloliw5Ifs5gTxQfhoaQYrql-RA">Dealmaking and Financing: Mergers and Acquisitions in the &#8230; - MarketWatch</a></p>
<p> <br />
Dealmaking and Financing: Mergers and Acquisitions in the &#8230;<br />
MarketWatch - 23 hours ago<br />
No facet of the biotech, specialty, or generics industries is being ignored; no technology platform, clinical product, or research program is unexplored or &#8230;<br />
Discover Key Issues to Consider When Bringing Biologics to Market &#8230;MarketWatch<br />
all 17 news articles
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/19/dealmaking-and-financing-mergers-and-acquisitions-in-the-marketwatch/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>A Practical Guide for the Pharmaceutical and Biotech Industries &#8230; - MarketWatch</title>
		<link>http://biotech.technewsblog.net/2008/08/18/a-practical-guide-for-the-pharmaceutical-and-biotech-industries-marketwatch/</link>
		<comments>http://biotech.technewsblog.net/2008/08/18/a-practical-guide-for-the-pharmaceutical-and-biotech-industries-marketwatch/#comments</comments>
		<pubDate>Mon, 18 Aug 2008 11:09:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/18/a-practical-guide-for-the-pharmaceutical-and-biotech-industries-marketwatch/</guid>
		<description><![CDATA[A Practical Guide for the Pharmaceutical and Biotech Industries &#8230; - MarketWatch

A Practical Guide for the Pharmaceutical and Biotech Industries &#8230;
MarketWatch - 7 hours ago
Pharmaceutical and biotech companies are outsourcing more of their work than ever before - the list includes drug discovery, development, manufacture and &#8230;
Explore the Fundamentals of Logistics in Bulgaria MarketWatch
all 14 [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.marketwatch.com/news/story/practical-guide-pharmaceutical-biotech-industries/story.aspx%3Fguid%3D%257B4FE4A661-FF87-44F1-AFEF-0EA50EA18D02%257D%26dist%3Dhppr&#038;cid=1237837280&#038;ei=V1ipSPmMKajA-wGV86ntDQ&#038;usg=AFQjCNE6qdPqF4iG-qy3PzGvXMb6Zd_MIg">A Practical Guide for the Pharmaceutical and Biotech Industries &#8230; - MarketWatch</a></p>
<p> <br />
A Practical Guide for the Pharmaceutical and Biotech Industries &#8230;<br />
MarketWatch - 7 hours ago<br />
Pharmaceutical and biotech companies are outsourcing more of their work than ever before - the list includes drug discovery, development, manufacture and &#8230;<br />
Explore the Fundamentals of Logistics in Bulgaria MarketWatch<br />
all 14 news articles
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/18/a-practical-guide-for-the-pharmaceutical-and-biotech-industries-marketwatch/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Recruiters eye Genentech employees - San Francisco Chronicle</title>
		<link>http://biotech.technewsblog.net/2008/08/17/recruiters-eye-genentech-employees-san-francisco-chronicle/</link>
		<comments>http://biotech.technewsblog.net/2008/08/17/recruiters-eye-genentech-employees-san-francisco-chronicle/#comments</comments>
		<pubDate>Sun, 17 Aug 2008 11:09:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/17/recruiters-eye-genentech-employees-san-francisco-chronicle/</guid>
		<description><![CDATA[Recruiters eye Genentech employees - San Francisco Chronicle

The Money Times

Recruiters eye Genentech employees
San Francisco Chronicle, USA - 8 hours ago
Analysts predicted a mass exodus of valued Genentech staffers after Roche, which had preserved the biotech pioneer&#8217;s independence for years, made a surprise &#8230;
Biotech firms play hard to getReuters UK
Just the drug for the biotechs Therapeutics [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.sfgate.com/cgi-bin/article.cgi%3Ff%3D/c/a/2008/08/16/BUN812BC2I.DTL&#038;cid=1236959693&#038;ei=1gaoSK2fBaaU-QGPnonwDQ&#038;usg=AFQjCNEvqbeSp3r3RpSY86wud-XKgq6f7Q">Recruiters eye Genentech employees - San Francisco Chronicle</a><br />
 <br />
The Money Times</p>
<p> <br />
Recruiters eye Genentech employees<br />
San Francisco Chronicle, USA - 8 hours ago<br />
Analysts predicted a mass exodus of valued Genentech staffers after Roche, which had preserved the biotech pioneer&#8217;s independence for years, made a surprise &#8230;<br />
Biotech firms play hard to getReuters UK<br />
Just the drug for the biotechs Therapeutics Daily (subscription) (press release)<br />
Roche/Genentech Financial Times<br />
Wall Street Journal - International Herald Tribune<br />
all 293 news articles
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/17/recruiters-eye-genentech-employees-san-francisco-chronicle/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Accelerator Corporation Creates Ninth New Biotech Company - FOXBusiness</title>
		<link>http://biotech.technewsblog.net/2008/08/16/accelerator-corporation-creates-ninth-new-biotech-company-foxbusiness/</link>
		<comments>http://biotech.technewsblog.net/2008/08/16/accelerator-corporation-creates-ninth-new-biotech-company-foxbusiness/#comments</comments>
		<pubDate>Sat, 16 Aug 2008 11:09:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/16/accelerator-corporation-creates-ninth-new-biotech-company-foxbusiness/</guid>
		<description><![CDATA[Accelerator Corporation Creates Ninth New Biotech Company - FOXBusiness

Accelerator Corporation Creates Ninth New Biotech Company
FOXBusiness - 3 hours ago
Accelerator Corporation, founded in 2003, is a privately-held biotechnology investment and development company located in Seattle, Washington, USA. &#8230;

]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.foxbusiness.com/story/markets/industries/finance/accelerator-corporation-creates-ninth-new-biotech-company/&#038;cid=1237335006&#038;ei=U7WmSMv9II_o-wG0n63zDQ&#038;usg=AFQjCNGdhl_gxHpy7NjTJ1nKh2GHokXIag">Accelerator Corporation Creates Ninth New Biotech Company - FOXBusiness</a></p>
<p> <br />
Accelerator Corporation Creates Ninth New Biotech Company<br />
FOXBusiness - 3 hours ago<br />
Accelerator Corporation, founded in 2003, is a privately-held biotechnology investment and development company located in Seattle, Washington, USA. &#8230;
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/16/accelerator-corporation-creates-ninth-new-biotech-company-foxbusiness/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Biotech firms play hard to get - Reuters UK</title>
		<link>http://biotech.technewsblog.net/2008/08/15/biotech-firms-play-hard-to-get-reuters-uk/</link>
		<comments>http://biotech.technewsblog.net/2008/08/15/biotech-firms-play-hard-to-get-reuters-uk/#comments</comments>
		<pubDate>Fri, 15 Aug 2008 11:09:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/15/biotech-firms-play-hard-to-get-reuters-uk/</guid>
		<description><![CDATA[Biotech firms play hard to get - Reuters UK

KCBS

Biotech firms play hard to get
Reuters UK, UK - Aug 13, 2008
Biotechnology company Genentech Inc on Wednesday followed ImClone Systems Incâs playbook by rejecting a takeover bid by its largest shareholder. &#8230;
Genentech: rejects Roche bid Pharmaceutical Business Review
Genentech Board Committee Rejects Roche&#8217;s $44 Billion Purchase Offer Wall [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://blogs.reuters.com/reuters-dealzone/2008/08/13/biotech-firms-play-hard-to-get/&#038;cid=1236959693&#038;ei=0WOlSPWaDIjO-AGP6ZT3DQ&#038;usg=AFQjCNFEUFdF1-m_P5kAci6hgpJx35usaA">Biotech firms play hard to get - Reuters UK</a><br />
 <br />
KCBS</p>
<p> <br />
Biotech firms play hard to get<br />
Reuters UK, UK - Aug 13, 2008<br />
Biotechnology company Genentech Inc on Wednesday followed ImClone Systems Incâ  s playbook by rejecting a takeover bid by its largest shareholder. &#8230;<br />
Genentech: rejects Roche bid Pharmaceutical Business Review<br />
Genentech Board Committee Rejects Roche&#8217;s $44 Billion Purchase Offer Wall Street Journal<br />
Genentech rejects takeover bid from Roche International Herald Tribune<br />
Forbes - Wall Street Journal Blogs<br />
all 286 news articles
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/15/biotech-firms-play-hard-to-get-reuters-uk/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Genentech rejects Roche offer as too low - San Francisco Chronicle</title>
		<link>http://biotech.technewsblog.net/2008/08/14/genentech-rejects-roche-offer-as-too-low-san-francisco-chronicle/</link>
		<comments>http://biotech.technewsblog.net/2008/08/14/genentech-rejects-roche-offer-as-too-low-san-francisco-chronicle/#comments</comments>
		<pubDate>Thu, 14 Aug 2008 11:09:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/14/genentech-rejects-roche-offer-as-too-low-san-francisco-chronicle/</guid>
		<description><![CDATA[Genentech rejects Roche offer as too low - San Francisco Chronicle

The Money Times

Genentech rejects Roche offer as too low
San Francisco Chronicle, USA - 2 hours ago
(08-13) 18:45 PDT &#8212; Biotech giant Genentech Inc. has rejected the surprise $43.7 billion takeover bid it received from Swiss drug giant Roche, &#8230;
Biotech firms play hard to getReuters UK
Genentech [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.sfgate.com/cgi-bin/article.cgi%3Ffile%3D/c/a/2008/08/14/MNB012AFLC.DTL&#038;cid=1236529634&#038;ei=TxKkSJaJG4jO-AGVzeS0CA&#038;usg=AFQjCNE4rAKqI9EuLmbJxUjZCR42LTPinw">Genentech rejects Roche offer as too low - San Francisco Chronicle</a><br />
 <br />
The Money Times</p>
<p> <br />
Genentech rejects Roche offer as too low<br />
San Francisco Chronicle, USA - 2 hours ago<br />
(08-13) 18:45 PDT &#8212; Biotech giant Genentech Inc. has rejected the surprise $43.7 billion takeover bid it received from Swiss drug giant Roche, &#8230;<br />
Biotech firms play hard to getReuters UK<br />
Genentech Board Committee Rejects Roche&#8217;s $44 Billion Purchase Offer Wall Street Journal<br />
Genentech rejects takeover bid from Roche International Herald Tribune<br />
Forbes - Wall Street Journal Blogs<br />
all 336 news articles
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/14/genentech-rejects-roche-offer-as-too-low-san-francisco-chronicle/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Biotech Group Expands Partnership Nationally With Wells Fargo - FOXBusiness</title>
		<link>http://biotech.technewsblog.net/2008/08/12/biotech-group-expands-partnership-nationally-with-wells-fargo-foxbusiness/</link>
		<comments>http://biotech.technewsblog.net/2008/08/12/biotech-group-expands-partnership-nationally-with-wells-fargo-foxbusiness/#comments</comments>
		<pubDate>Tue, 12 Aug 2008 11:09:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/12/biotech-group-expands-partnership-nationally-with-wells-fargo-foxbusiness/</guid>
		<description><![CDATA[Biotech Group Expands Partnership Nationally With Wells Fargo - FOXBusiness

Biotech Group Expands Partnership Nationally With Wells Fargo
FOXBusiness - 2 hours ago
The partnership encompasses participating state and regional biotechnology associations. Combined, over 5200 biotechnology companies and organizations &#8230;
Wells Fargo Insurance Services enters into partnership with BIO Insurance Business Review
all 2 news articles

]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.foxbusiness.com/story/markets/industries/finance/biotech-group-expands-partnership-nationally-wells-fargo/&#038;cid=1236110051&#038;ei=TW-hSPe-L47I8AT86NmCDA&#038;usg=AFQjCNFSualWKRsF7XeLSfOjZ-Rkf_0rKQ">Biotech Group Expands Partnership Nationally With Wells Fargo - FOXBusiness</a></p>
<p> <br />
Biotech Group Expands Partnership Nationally With Wells Fargo<br />
FOXBusiness - 2 hours ago<br />
The partnership encompasses participating state and regional biotechnology associations. Combined, over 5200 biotechnology companies and organizations &#8230;<br />
Wells Fargo Insurance Services enters into partnership with BIO Insurance Business Review<br />
all 2 news articles
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/12/biotech-group-expands-partnership-nationally-with-wells-fargo-foxbusiness/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>VC-owned companies argue for research program eligibility - MLive.com</title>
		<link>http://biotech.technewsblog.net/2008/08/11/vc-owned-companies-argue-for-research-program-eligibility-mlivecom/</link>
		<comments>http://biotech.technewsblog.net/2008/08/11/vc-owned-companies-argue-for-research-program-eligibility-mlivecom/#comments</comments>
		<pubDate>Mon, 11 Aug 2008 11:09:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/11/vc-owned-companies-argue-for-research-program-eligibility-mlivecom/</guid>
		<description><![CDATA[VC-owned companies argue for research program eligibility - MLive.com

VC-owned companies argue for research program eligibility
MLive.com, MI - 4 hours ago
They contend small biotech companies are forced to turn to venture capital because bringing new drugs and other innovations to market takes a lot of time &#8230;

]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.mlive.com/business/ambizdaily/bizjournals/index.ssf%3F/base/abd-4/1218436813140050.xml&#038;cid=1235770933&#038;ei=1h2gSLfUEaDe-AHvv7jDCw&#038;usg=AFQjCNGrz79OavM2mKKrNqO6634Mir-cvA">VC-owned companies argue for research program eligibility - MLive.com</a></p>
<p> <br />
VC-owned companies argue for research program eligibility<br />
MLive.com, MI - 4 hours ago<br />
They contend small biotech companies are forced to turn to venture capital because bringing new drugs and other innovations to market takes a lot of time &#8230;
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/11/vc-owned-companies-argue-for-research-program-eligibility-mlivecom/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Biotech-Stock Mailbag: Titan, Gilead - TheStreet.com</title>
		<link>http://biotech.technewsblog.net/2008/08/10/biotech-stock-mailbag-titan-gilead-thestreetcom/</link>
		<comments>http://biotech.technewsblog.net/2008/08/10/biotech-stock-mailbag-titan-gilead-thestreetcom/#comments</comments>
		<pubDate>Sun, 10 Aug 2008 11:09:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/10/biotech-stock-mailbag-titan-gilead-thestreetcom/</guid>
		<description><![CDATA[Biotech-Stock Mailbag: Titan, Gilead - TheStreet.com

Biotech-Stock Mailbag: Titan, Gilead
TheStreet.com - 12 hours ago
Thanks for returning to the weekly Biotech Mailbag. Our first question comes from Anh N., who asks: &#8220;Could you comment on the future of Titan &#8230;

]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.thestreet.com/p/_googlepi/rmoney/biotech/10432299.html&#038;cid=0&#038;ei=VcyeSMCNC5eY-QH25smzCw&#038;usg=AFQjCNHiq29sMWP7Qyj4_vu1wA_Ue0AlUg">Biotech-Stock Mailbag: Titan, Gilead - TheStreet.com</a></p>
<p> <br />
Biotech-Stock Mailbag: Titan, Gilead<br />
TheStreet.com - 12 hours ago<br />
Thanks for returning to the weekly Biotech Mailbag. Our first question comes from Anh N., who asks: &#8220;Could you comment on the future of Titan &#8230;
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/10/biotech-stock-mailbag-titan-gilead-thestreetcom/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Biotech firm proves it is no shrimp - TheChronicleHerald.ca</title>
		<link>http://biotech.technewsblog.net/2008/08/09/biotech-firm-proves-it-is-no-shrimp-thechronicleheraldca/</link>
		<comments>http://biotech.technewsblog.net/2008/08/09/biotech-firm-proves-it-is-no-shrimp-thechronicleheraldca/#comments</comments>
		<pubDate>Sat, 09 Aug 2008 11:09:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://biotech.technewsblog.net/2008/08/09/biotech-firm-proves-it-is-no-shrimp-thechronicleheraldca/</guid>
		<description><![CDATA[Biotech firm proves it is no shrimp - TheChronicleHerald.ca

Biotech firm proves it is no shrimp
TheChronicleHerald.ca, Canada - 1 hour ago
By CLARE MELLOR Business Reporter âIt is for healing wounds, burns or cuts, things like that,&#8221; Ms. Zazanis said Thursday from New Jersey. &#8230;

]]></description>
			<content:encoded><![CDATA[<p><a rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://thechronicleherald.ca/Business/9007887.html&#038;cid=0&#038;ei=0nqdSMH9JobW-wG42cS9Cw&#038;usg=AFQjCNFqEtYa2SX5UbTMIMFAXvSebnCXXg">Biotech firm proves it is no shrimp - TheChronicleHerald.ca</a></p>
<p> <br />
Biotech firm proves it is no shrimp<br />
TheChronicleHerald.ca, Canada - 1 hour ago<br />
By CLARE MELLOR Business Reporter â  It is for healing wounds, burns or cuts, things like that,&#8221; Ms. Zazanis said Thursday from New Jersey. &#8230;
</p>
]]></content:encoded>
			<wfw:commentRSS>http://biotech.technewsblog.net/2008/08/09/biotech-firm-proves-it-is-no-shrimp-thechronicleheraldca/feed/</wfw:commentRSS>
		</item>
	</channel>
</rss>
